Frank Rimerman Advisors LLC bought a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the 1st quarter, Holdings Channel.com reports. The firm bought 5,994 shares of the financial services provider’s stock, valued at approximately $1,040,000.
Other institutional investors have also added to or reduced their stakes in the company. Lmcg Investments LLC purchased a new position in shares of Marsh & McLennan Companies during the 1st quarter worth $991,000. Childress Capital Advisors LLC purchased a new stake in shares of Marsh & McLennan Companies in the 1st quarter worth $314,000. Flatrock Wealth Partners LLC bought a new position in Marsh & McLennan Companies in the 1st quarter worth $250,000. Duncker Streett & Co. Inc. purchased a new position in Marsh & McLennan Companies during the first quarter valued at $555,000. Finally, Montag A & Associates Inc. bought a new stake in Marsh & McLennan Companies during the first quarter valued at about $429,000. 87.99% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Several research firms have recently commented on MRSH. Cantor Fitzgerald raised their price objective on Marsh & McLennan Companies from $210.00 to $218.00 and gave the stock an “overweight” rating in a research note on Thursday. Citigroup raised shares of Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 target price for the company in a report on Wednesday, May 6th. Wells Fargo & Company decreased their target price on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 9th. UBS Group lifted their price target on shares of Marsh & McLennan Companies from $203.00 to $212.00 and gave the company a “buy” rating in a report on Wednesday. Finally, Morgan Stanley reduced their price objective on shares of Marsh & McLennan Companies from $180.00 to $175.00 and set an “equal weight” rating for the company in a research note on Monday. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $200.44.
Marsh & McLennan Companies Price Performance
MRSH stock opened at $178.81 on Friday. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.28. Marsh & McLennan Companies, Inc. has a one year low of $156.60 and a one year high of $216.32. The firm has a market capitalization of $86.38 billion, a PE ratio of 22.35, a P/E/G ratio of 2.61 and a beta of 0.61.
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last posted its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, beating the consensus estimate of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The company had revenue of $7.30 billion during the quarter. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. As a group, analysts anticipate that Marsh & McLennan Companies, Inc. will post 10.37 earnings per share for the current fiscal year.
Marsh & McLennan Companies Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Thursday, July 23rd will be given a dividend of $0.99 per share. The ex-dividend date is Thursday, July 23rd. This represents a $3.96 annualized dividend and a dividend yield of 2.2%. This is a positive change from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. Marsh & McLennan Companies’s dividend payout ratio is currently 45.00%.
Trending Headlines about Marsh & McLennan Companies
Here are the key news stories impacting Marsh & McLennan Companies this week:
- Positive Sentiment: UBS reiterated its Buy rating and raised its price target on Marsh & McLennan Companies (MRSH) to $212, signaling confidence in further upside. UBS Sticks to Their Buy Rating for Marsh & McLennan Companies (MRSH)
- Positive Sentiment: Cantor Fitzgerald also lifted its price target on MRSH to $218 and kept an Overweight rating, reinforcing the view that the shares still have meaningful upside. Benzinga report on Cantor Fitzgerald price target increase
- Positive Sentiment: Marsh & McLennan raised its quarterly dividend by 10% to $0.99 per share, a sign of strong cash generation and continued commitment to returning capital to shareholders. Marsh Raises Dividend: Is Its Capital Return Story Getting Stronger?
- Neutral Sentiment: Mizuho modestly increased its price target to $197 while keeping a Neutral rating, adding to the overall analyst attention but offering a more balanced view. Benzinga report on Mizuho price target increase
- Neutral Sentiment: The company also formally declared the new quarterly dividend, payable in August, confirming the higher payout and supporting the stock’s income appeal. Dividend declaration details
Insider Activity at Marsh & McLennan Companies
In related news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the completion of the transaction, the chief executive officer owned 116,811 shares in the company, valued at approximately $18,889,506.81. This trade represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company’s stock.
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Featured Articles
- Five stocks we like better than Marsh & McLennan Companies
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
